FB704A
Severe Asthma
Phase 1Active
Key Facts
About Oneness Biotech
Taiwanese biotech delivering Phase 3 wound‑care therapy and a diversified pipeline across dermatology, immunology and metabolism.
View full company profileTherapeutic Areas
Other Severe Asthma Drugs
| Drug | Company | Phase |
|---|---|---|
| Depemokimab (GSK3511294) | GSK | Phase III |
| Spiro Neuromodulation System | Spiro Medical | Phase 2 |
| Severe Asthma (FFA4 receptor) | Keltic Pharma Therapeutics | Pre-clinical |
| KN-002 | Kinaset Therapeutics | Pre-clinical |
| GB-0895 | Generate Biomedicines | Phase 3 |
| Verekitug (UPB-101) | Upstream Bio | Phase 2 |